CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Operating Activities:
Net income	$ 83.0	$ 80.2
Adjustments to reconcile net income to net cash from continuing operating activities:
Depreciation	22.4	20.8
Earnings of equity method investments	(13.2)	(5.5)
Loss from discontinued operations, net of tax	0.6
Deferred income taxes	42.5	3.9
Changes in operating assets and liabilities:
Accounts receivable	33.5	(53.2)
Inventories	(52.5)	(49.7)
Floor plan notes payable	20.4	15.3
Accounts payable and accrued expenses	86.0	56.3
Other	(24.1)	14.5
Net cash provided by continuing operating activities	198.6	82.6
Investing Activities:
Purchase of equipment and improvements	(36.9)	(46.8)
Acquisitions net, including repayment of sellers’ floor plan notes payable of $81.2 and $0.0, respectively	(314.2)	(0.4)
Other	9.0	(25.7)
Net cash used in continuing investing activities	(342.1)	(72.9)
Financing Activities:
Proceeds from borrowings under U.S. credit agreement revolving credit line	523.0	372.5
Repayments under U.S. credit agreement revolving credit line	(476.0)	(295.5)
Net borrowings of other long-term debt	106.1	34.5
Net borrowings of floor plan notes payable — non-trade	63.0	54.9
Repurchases of common stock	(2.7)	(167.9)
Dividends	(25.6)	(23.3)
Other		(4.6)
Net cash provided by (used in) continuing financing activities	187.8	(29.4)
Discontinued operations:
Net cash (used in) provided by discontinued operating activities	(7.0)	0.5
Net cash provided by discontinued investing activities	9.7	1.7
Net cash used in discontinued financing activities	(0.2)
Net cash provided by discontinued operations	2.5	2.2
Effect of exchange rate changes on cash and cash equivalents	1.4	0.7
Net change in cash and cash equivalents	48.2	(16.8)
Cash and cash equivalents, beginning of period	24.0	62.4
Cash and cash equivalents, end of period	72.2	45.6
Cash paid (received) for:
Interest	20.3	18.4
Income taxes	(8.4)	$ 13.1
Seller financed/assumed debt	3.8
Non cash activities:
Consideration transferred through common stock issuance	32.4
Contingent consideration	$ 20.0